Rozlytrek, Rozlytrek, Rozlytrek
CO40778
Phase 2 small_molecule active
Quick answer
Rozlytrek, Rozlytrek, Rozlytrek for Pediatric Solid tumors and primary central nervous system (CNS) tumors is a Phase 2 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Pediatric Solid tumors and primary central nervous system (CNS) tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active